top of page

RYGB is effective in men with individualised follow-up protocols

Roux-en-Y gastric bypass (RYGB) is effective in men with obesity, demonstrating substantial excess weight loss and significant long-term improvements in obesity-related comorbidities, according to researchers from Brazil. However, the researchers emphasise the need to individualise follow-up protocols, targeted education, and culturally sensitive interventions to improve engagement, adherence, and long-term outcomes in male bariatric patients.


ree

The researchers from the University of Brasília and Hospital Santa Lúcia, Brasília, Distrito Federal, Brazil, explained that whilst men constitute a minority of bariatric surgery patients - despite facing a high burden of obesity-related complications - little is known about factors influencing long-term weight outcomes in male patients. As a result, they sought to identify clinical and behavioural determinants of weight loss maintenance, and weight regain in men after RYGB. The analysis aimed to contribute to sex-specific understanding of postoperative outcomes, thereby informing more personalised strategies for long-term success.


For the study, they retrospectively reviewed 100 men with obesity who underwent laparoscopic RYGB between 2013 and 2016. Inclusion was limited to those with ≥ 2 years of postoperative follow-up, subsequently, 43 male patients were available for analysis. Clinical variables (age and comorbidities), behavioural factors (exercise and dumping syndrome - DS), and weight data were collected. Poisson regression identified factors associated with achieving normal body mass index (BMI) and significant weight regain. A linear regression model assessed predictors of percent excess weight loss (%EWL).


Outcomes

The mean age of the included 43 patients was 39.7 years (40 ± 11), with an average follow-up of 48.3 months (48 ± 22). Among the included cohort, the mean percentage of excess weight loss (%EWL) achieved was 84.5% (85 ± 19), with 27.9% of patients reaching a normal BMI. Of the 43 participants, the majority presented multiple obesity complications preoperatively, including diabetes mellitus (67%), hypertension (69.7%) and dyslipidaemia (57.1%). Twenty-one of 43 patients reported DS (48,8%).


Half of the participants (50%) reported dumping syndrome (DS) post-RYGB, and its presence was significantly associated with achieving a normal BMI (p=0.03). No other measured factors (eg, age, comorbidity burden, or exercise) emerged as significant predictors of normal BMI in this cohort.

In the initial simple Poisson regression analysis, no variable showed a statistically significant association (p < 0.05) with achieving a normal BMI. However, in the multiple Poisson regression model, only the presence of DS was significantly associated with this outcome. Men who reported DS had a 186% higher chance (PR of 2.86) of achieving a normal BMI compared to those without it, after adjusting for other covariates (p=0.0309).


Only the length of postoperative follow-up showed a significant correlation (p<0.0001). In the simple Poisson regression model, follow-up time was the only variable significantly associated with weight regain >15% relative to the lowest recorded weight (p<0.05). This association remained significant in the multiple Poisson regression model. Each additional month of follow-up was associated with a 4% increase in the prevalence of weight regain >15%, independent of other variables (p<0.0001).


In the initial simple Poisson regression analysis, only follow-up time was significantly associated with the occurrence of weight regain ≥ 20% TWL (p<0.05). In the subsequent multiple Poisson regression model, both follow-up time and achieving a normal BMI were significantly associated with this outcome.


Each additional year of follow-up was associated with a 4% increase in the chances of significant weight regain (≥20% TWL), after adjusting for other variables (p=0.0003). Additionally, men who reached a normal BMI had a 155% higher (PR of 2.55) chance of weight regain ≥20% TWL compared to those who did not, independent of other covariates (p=0.0205).


Initially, in the simple linear regression analysis, only the variable normal BMI showed a statistically significant association (p<0.05) with EWL. Subsequently, in the multiple linear regression model, normal BMI remained the only variable significantly associated with EWL. Men who achieved a normal BMI had, on average, a 30.30% greater excess weight loss compared to those who did not, after adjusting for other variables (p<0.0001).


“As expected, men who had a higher %EWL achieved more frequently a normal BMI after surgery. Despite significant preoperative comorbidity burden, male patients achieved substantial excess weight loss (mean %EWL 84.5%) and a notable reduction in BMI over follow-up period, reinforcing the efficacy of RYGB in our study population,” the authors noted. “As shown in previous studies, male BMS candidates can benefit from focused interventions for longer follow-up, psychological support, and behavioural adherence to mitigate weight regain.”


The findings were reported in the paper, ‘Determinants of Weight Loss and Regain in Men After Roux-En-Y Gastric Bypass: A Retrospective Analysis’, published in the journal Diabetes, Metabolic Syndrome and Obesity. To access this paper, please click here

Comments


Weekly Digest

Get a round-up of the main headlines from Bariatric News, directly to your inbox each week.

Thanks for submitting!

Get in touch!
Email: info@bariatricnews.net

©2023 Dendrite Clinical Systems Ltd. All rights reserved.
No part of this website may be reproduced, stored in a retrieval system, transmitted in any form or by any other means without prior written permission from the Managing Editor. The views, comments and opinions expressed within are not necessarily those of Dendrite Clinical Systems or the Editorial Board. Bariatricnews.net is a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

bottom of page